Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)

China · Delayed Price · Currency is CNY

12.82

+0.01 (0.08%)

Feb 27, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Active Pharmaceutical Ingredient (API)	356.16M	554.61M	426.89M	464.61M	548.06M
Active Pharmaceutical Ingredient (API) Growth	-35.78%	29.92%	-8.12%	-15.23%	-
Preparations	85.21M	103.38M	86.47M	75.13M	44.29M
Preparations Growth	-17.57%	19.56%	15.08%	69.63%	-
Others	4.49M	5.04M	1.56M	872.97K	566.59K
Others Growth	-10.75%	223.45%	78.36%	54.07%	-
Total	445.86M	663.03M	514.91M	540.62M	592.92M
Total Growth	-32.75%	28.76%	-4.76%	-8.82%	-10.17%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	236.99M	410.77M	277.03M	266.14M	178.75M
China Growth	-42.30%	48.27%	4.09%	48.89%	-25.46%
Overseas	208.87M	252.26M	237.88M	274.48M	414.17M
Overseas Growth	-17.20%	6.04%	-13.34%	-33.73%	-
Total	445.86M	663.03M	514.91M	540.62M	592.92M
Total Growth	-32.75%	28.76%	-4.76%	-8.82%	-9.94%

Source: S&P Global Market Intelligence.